Skip to main content

Bayesian Multiclass Classification of Gene Expression Colorectal Cancer Stages

  • Conference paper
ICT Innovations 2013 (ICT Innovations 2013)

Part of the book series: Advances in Intelligent Systems and Computing ((AISC,volume 231))

Included in the following conference series:

Abstract

Recent researches of Colorectal Cancer (CRC) aim to look for the answers for its occurrence in the disrupted gene expressions by examining colorectal carcinogenic and healthy tissues with different microarray technologies. In this paper, we propose a novel generative modelling of the Bayes’ classification for the CRC problem in order to differentiate between colorectal cancer stages. The main contribution of this paper is the solution of the distinguishing problem between the critical CRC stages that remained unsolved in the published materials - distinguishing the stage I with stage IV, and stage II with stage III. The Bayesian classifier enabled application of the ’smoothing procedure’ over the data from the third stage, which succeeded to distinguish the probabilities of the mentioned stages. This results are obtained as a continuation of our previous work, where we proposed methodologies for statistical analysis of colorectal gene expression data obtained from the two widely used platforms, Affymetrix and Illumina. Furthermore, the unveiled biomarkers from the two platforms were used in our generative approach for modelling the gene expression probability distribution and were used in the Bayes’ classification system, where we performed binary classifications. This novel approach will help in producing an accurate diagnostics system and precising the actual stage of the cancer. It is of great advantage for early prognosis of the disease and appropriate treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. GLOBOCAN (2008), http://globocan.iarc.fr/factsheets/cancers/colorectal.asp

  2. Jain, K.: Applications of biochips: From diagnostics to personalized medicine. Current Opinion in Drug Disc. & Develop. 7(3), 285–289 (2004)

    Google Scholar 

  3. Simjanoska, M., Bogdanova, A.M., Popeska, Z.: Bayesian posterior probability classification of colorectal cancer probed with affymetrix microarray technology. In: Proceedings of the 36th International Convention, MIPRO, CIS Intelligent Systems (2013)

    Google Scholar 

  4. NCI: Colon cancer treatment (2013), http://www.cancer.gov/cancertopics/pdq/treatment/colon/Patient/page2

  5. Eschrich, S., Yang, I., Bloom, G., Kwong, K.Y., Boulware, D., Cantor, A., Coppola, D., Kruhøffer, M., Aaltonen, L., Orntoft, T.F., et al.: Molecular staging for survival prediction of colorectal cancer patients. Journal of Clinical Oncology 23(15), 3526–3535 (2005)

    Article  Google Scholar 

  6. Salazar, R., Roepman, P., Capella, G., Moreno, V., Simon, I., Dreezen, C., Lopez-Doriga, A., Santos, C., Marijnen, C., Westerga, J., et al.: Gene expression signature to improve prognosis prediction of stage ii and iii colorectal cancer. Journal of clinical oncology 29(1), 17–24 (2011)

    Article  Google Scholar 

  7. Donada, M., Bonin, S., Barbazza, R., Pettirosso, D., Stanta, G.: Management of stage ii colon cancer-the use of molecular biomarkers for adjuvant therapy decision. BMC Gastroenterology 13(1), 1–13 (2013)

    Article  Google Scholar 

  8. Ahmed, F.E.: Artificial neural networks for diagnosis and survival prediction in colon cancer. Molecular Cancer 4(1), 29 (2005)

    Article  Google Scholar 

  9. Frederiksen, C.M., Knudsen, S., Laurberg, S., Ørntoft, T.F.: Classification of dukes’ b and c colorectal cancers using expression arrays. Journal of Cancer Research and Clinical Oncology 129(5), 263–271 (2003)

    Google Scholar 

  10. Laibe, S., Lagarde, A., Ferrari, A., Monges, G., Birnbaum, D., Olschwang, the COL2 Project, S.: A seven-gene signature aggregates a subgroup of stage ii colon cancers with stage iii. OMICS: A Journal of Integrative Biology 16(10), 560–565 (2012)

    Google Scholar 

  11. Tsukamoto, S., Ishikawa, T., Iida, S., Ishiguro, M., Mogushi, K., Mizushima, H., Uetake, H., Tanaka, H., Sugihara, K.: Clinical significance of osteoprotegerin expression in human colorectal cancer. Clinical Cancer Research 17(8), 2444–2450 (2011)

    Article  Google Scholar 

  12. Hong, Y., Downey, T., Eu, K.W., Koh, P.K., Cheah, P.Y.: A metastasis-pronesignature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clinical & Experimental Metastasis 27(2), 83–90 (2010)

    Article  Google Scholar 

  13. Jorissen, R.N., Gibbs, P., Christie, M., Prakash, S., Lipton, L., Desai, J., Kerr, D., Aaltonen, L.A., Arango, D., Kruhøffer, M., et al.: Metastasis-associated gene expression changes predict poor outcomes in patients with dukes stage b and c colorectal cancer. Clinical Cancer Research 15(24), 7642–7651 (2009)

    Article  Google Scholar 

  14. Schlicker, A., Beran, G., Chresta, C.M., McWalter, G., Pritchard, A., Weston, S., Runswick, S., Davenport, S., Heathcote, K., Castro, D.A., et al.: Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines. BMC Medical Genomics 5(1), 66 (2012)

    Article  Google Scholar 

  15. OConnell, J.B., Maggard, M.A., Ko, C.Y.: Colon cancer survival rates with the new american joint committee on cancer sixth edition staging. Journal of the National Cancer Institute 96(19), 1420–1425 (2004)

    Article  Google Scholar 

  16. Gene expression omnibus (2013), http://www.ncbi.nlm.nih.gov/geo/

  17. MayoClinic: Colon cancer (2013), http://www.mayoclinic.com/health/colon-cancer/DS00035/DSECTION=tests-and-diagnosis

  18. Wu, Z., Aryee, M.: Subset quantile normalization using negative control features. Journal of Computational Biology 17(10), 1385–1395 (2010)

    Article  MathSciNet  Google Scholar 

  19. Hui, Y., Kang, T., Xie, L., Yuan-Yuan, L.: Digout: Viewing differential expression genes as outliers. Journal of Bioinformatics and Computational Biology 8(supp. 01), 161–175 (2010)

    Google Scholar 

  20. Tamayo, P., Slonim, D., Mesirov, J., Zhu, Q., Kitareewan, S., Dmitrovsky, E., Lander, E.S., Golub, T.R.: Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation. Proceedings of the National Academy of Sciences 96(6), 2907–2912 (1999)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Monika Simjanoska .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this paper

Cite this paper

Simjanoska, M., Bogdanova, A.M., Popeska, Z. (2014). Bayesian Multiclass Classification of Gene Expression Colorectal Cancer Stages. In: Trajkovik, V., Anastas, M. (eds) ICT Innovations 2013. ICT Innovations 2013. Advances in Intelligent Systems and Computing, vol 231. Springer, Heidelberg. https://doi.org/10.1007/978-3-319-01466-1_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-01466-1_17

  • Publisher Name: Springer, Heidelberg

  • Print ISBN: 978-3-319-01465-4

  • Online ISBN: 978-3-319-01466-1

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics